Keck School Faculty

Robert Alan Kloner, MD, PhD
Robert Alan Kloner, MD, PhD
Professor of Medicine (Clinical Scholar)
Medicine
IRD 620 Off Campus Los Angeles

Consumer's Research Council of America: Listed in Guide to America's Top Cardiologists, 2007

Good Samaritan Hospital : Physician Leadership Award, 2003

Institute for Scientific Information: Identified as one of the world's most highly cited authors, 2002

American Heart Association: Inaugural Fellow of the Council on Basic Cardiovascular Sciences, 2001

United States Israel Binational Science Foundation: The Henry N. Neufeld Memorial Award, 1996

NIH: Cardiovascular Study Section A, 1995-1998

American Heart Association : Continuing Service Award, 1991

American Society for Clinical Investigation: Elected Member, 1990

82nd Annual Scientific Assembly of the Southern Medical Association: Scientific Exhibit Achievement Award, 1988

American College of Physicians: Research Prize, 1988

American Heart Association: Recipient of the Established Investigatorship Award, 1981-1986

American Society of Clinical Pathologists: Sheard-Sanford Award for Meritorius Original Student Research in Pathology During Medical School, 1976

Merck: Award for Outstanding Achievement in the Study of Medicine, 1975

Alpha Omega Alpha: Member, 1973

Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction J Cardiovasc Transl Res. 2019 Jan 22. . View in PubMed

Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction J Cardiovasc Pharmacol Ther. 2018 Dec 18; 1074248418812167. . View in PubMed

Acute and Subacute Triggers of Cardiovascular Events Am J Cardiol. 2018 Dec 15; 122(12):2157-2165. . View in PubMed

A Thank You From the Editor-in-Chief J Cardiovasc Pharmacol Ther. 2018 Nov 14; 1074248418807813. . View in PubMed

Cardiovascular effects of marijuana Trends Cardiovasc Med. 2018 Nov 10. . View in PubMed

Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors J Cardiovasc Pharmacol Ther. 2018 Nov; 23(6):524-531. . View in PubMed

Acute and Subacute Triggers of Cardiovascular Events Am J Cardiol. 2018 Sep 13. . View in PubMed

A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction J Cardiovasc Pharmacol Ther. 2018 Sep; 23(5):375-386. . View in PubMed

Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors J Cardiovasc Pharmacol Ther. 2018 Aug 14; 1074248418788334. . View in PubMed

Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market Sex Med Rev. 2018 Jun 27. . View in PubMed

Cardiorenal Safety of OTC Analgesics J Cardiovasc Pharmacol Ther. 2018 Mar; 23(2):103-118. . View in PubMed

Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market Sex Med Rev. 2018 10; 6(4):583-594. . View in PubMed

Cardiorenal Safety of OTC Analgesics J Cardiovasc Pharmacol Ther. 2018 03; 23(2):103-118. . View in PubMed

A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction J Cardiovasc Pharmacol Ther. 2018 Jan 01; 1074248418771896. . View in PubMed

Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model Int J Cardiol. 2017 Jun 01; 236:400-404. . View in PubMed

Cardioprotection: Where to from here? Cardiovasc Drugs Ther. 2017 Feb; 31(1):53-61.. View in PubMed

Angina and Its Management J Cardiovasc Pharmacol Ther. 2017 05; 22(3):199-209. . View in PubMed

Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion Cardiovasc Drugs Ther. 2016 Dec; 30(6):559-566. . View in PubMed

Cardiovascular Effects of Marijuana J Cardiovasc Pharmacol Ther. 2016 09; 21(5):452-5. . View in PubMed

Approaches to Improving Cardiac Structure and Function During and After an Acute Myocardial Infarction: Acute and Chronic Phases J Cardiovasc Pharmacol Ther. 2016 07; 21(4):363-7. . View in PubMed

Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart Life Sci. 2015 Nov 15; 141:170-8. . View in PubMed

Cardiovascular consequences of cocaine use Trends Cardiovasc Med. 2015 Aug; 25(6):517-26. . View in PubMed

Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion J Thromb Thrombolysis. 2015 Jan; 39(1):50-4. . View in PubMed

Does sex influence the incidence or severity of reperfusion-induced cardiac arrhythmias? Springerplus. 2015; 4:96.. View in PubMed

Bendavia, a mitochondria-targeting peptide, improves postinfarction cardiac function, prevents adverse left ventricular remodeling, and restores mitochondria-related gene expression in rats J Cardiovasc Pharmacol. 2014 Dec; 64(6):543-53. . View in PubMed

Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion J Cardiovasc Pharmacol Ther. 2014 Nov; 19(6):567-73. . View in PubMed

Is hypothermia or the salvage kinase pathway involved? Cardiovasc Drugs Ther. 2014 Aug; 28(4):295-301.. View in PubMed

A systematic review of the association between erectile dysfunction and cardiovascular disease Eur Urol. 2014 May; 65(5):968-78. . View in PubMed

All men with vasculogenic erectile dysfunction require a cardiovascular workup Am J Med. 2014 Mar; 127(3):174-82. . View in PubMed

Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know Am J Cardiol. 2014 Jan 01; 113(1):187-90. . View in PubMed

Current state of clinical translation of cardioprotective agents for acute myocardial infarction Circ Res. 2013 Aug 02; 113(4):451-63. . View in PubMed

Can myocardial infarct size be reduced by mechanically unloading the left ventricle? Circulation. 2013 Jul 23; 128(4):318-21.. View in PubMed

Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk J Urol. 2013 Jun; 189(6):2031-8. . View in PubMed

A brief review of useful tips for publishing your scientific manuscript J Cardiovasc Pharmacol Ther. 2013 May; 18(3):197-8. . View in PubMed

Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size J Am Heart Assoc. 2013 Jan 04; 2(1):e004234. . View in PubMed

Continuous heliox breathing and the extent of anatomic zone of noreflow and necrosis following ischemia/reperfusion in the rabbit heart Open Cardiovasc Med J. 2013; 8:1-5. . View in PubMed

Absence of actions of commonly used Chinese herbal medicines and electroacupuncture on myocardial infarct size J Cardiovasc Pharmacol Ther. 2012 Dec; 17(4):403-11. . View in PubMed

An apoptosis signal-regulating kinase 1 inhibitor reduces cardiomyocyte apoptosis and infarct size in a rat ischemia-reperfusion model J Cardiovasc Pharmacol. 2012 Sep; 60(3):276-82. . View in PubMed

Devices to treat peripheral chronic total occlusions J Interv Cardiol. 2012 Aug; 25(4):395-403. . View in PubMed

Coronary no reflow J Mol Cell Cardiol. 2012 Apr; 52(4):873-82. . View in PubMed

An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials J Am Coll Cardiol. 2012 Mar 13; 59(11):969-78. . View in PubMed

Cardiac uses of phosphodiesterase-5 inhibitors J Am Coll Cardiol. 2012 Jan 03; 59(1):9-15. . View in PubMed

Diannexin reduces no-reflow after reperfusion in rabbits with large ischemic myocardial risk zones Cardiovasc Ther. 2011 Aug; 29(4):e42-52. . View in PubMed

Cardioprotection of insulin-like growth factor-1 during reperfusion therapy: what is the underlying mechanism or mechanisms? Circ Cardiovasc Interv. 2011 Aug; 4(4):311-3.. View in PubMed

Cardiology patient page: cardiovascular implications of erectile dysfunction Circulation. 2011 May 31; 123(21):e609-11. . View in PubMed

Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease Circulation. 2011 Jan 04; 123(1):98-101. . View in PubMed

Cardiovascular effects of cocaine Circulation. 2010 Dec 14; 122(24):2558-69. . View in PubMed

Effects of zoledronate in the repair of chronically infarcted rat myocardium J Cardiovasc Pharmacol. 2010 Dec; 56(6):604-9. . View in PubMed

Blood supply of the graft after cellular cardiomyoplasty Regen Med. 2010 Sep; 5(5):777-86. . View in PubMed

Comparison of automated oscillometric versus auscultatory blood pressure measurement Am J Cardiol. 2010 Aug 01; 106(3):386-8. . View in PubMed

Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension Circulation. 2010 Jul 06; 122(1):88-95. . View in PubMed

Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit J Cardiovasc Pharmacol Ther. 2010 Mar; 15(1):60-7. . View in PubMed

Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model Cardiovasc Ther. 2010; 28(1):30-7. . View in PubMed

ATL 313, A Selective A(2A) Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion Model Open Cardiovasc Med J. 2009 Nov 25; 3:166-72. . View in PubMed

Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy J Biol Chem. 2009 Sep 11; 284(37):24857-68. . View in PubMed

A salute to our founding editor-in-chief Bramah NSingh, MD, DPhil, DSc, FRCP. J Cardiovasc Pharmacol Ther. 2009 Sep; 14(3):154-6. . View in PubMed

Comparison of total and cardiovascular death rates in the same city during a losing versus winning super bowl championship Am J Cardiol. 2009 Jun 15; 103(12):1647-50. . View in PubMed

Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology Regen Med. 2009 May; 4(3):387-95. . View in PubMed

Complication rate of diagnostic carotid angiography performed by interventional cardiologists Catheter Cardiovasc Interv. 2009 Apr 01; 73(5):661-5. . View in PubMed

Clinical application of remote ischemic preconditioning Circulation. 2009 Feb 17; 119(6):776-8. . View in PubMed

Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory Catheter Cardiovasc Interv. 2008 Dec 01; 72(7):950-7. . View in PubMed

Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial Ann Pharmacother. 2008 Nov; 42(11):1552-62. . View in PubMed

Direct and acute cardiotoxic effects of ultrafine air pollutants in spontaneously hypertensive rats and Wistar--Kyoto rats J Cardiovasc Pharmacol Ther. 2008 Sep; 13(3):189-98. . View in PubMed

Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms J Am Coll Cardiol. 2008 Aug 26; 52(9):719-26. . View in PubMed

Direct and acute cardiotoxicity of ultrafine particles in young adult and old rat hearts Basic Res Cardiol. 2007 Nov; 102(6):467-75. . View in PubMed

Case studies: applying JNC-7 treatment guidelines JAAPA. 2007 Nov; Suppl Hypertension:14-8. . View in PubMed

Cocaine-induced acute myocardial infarction Clin Med Res. 2007 Oct; 5(3):172-6. . View in PubMed

Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse J Endocrinol. 2007 Jul; 194(1):63-76. . View in PubMed

Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: a pilot study J Vasc Surg. 2007 Apr; 45(4):817-20. . View in PubMed

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threatsTask Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. Circulation. 2007 Mar 27; 115(12):1672-80. . View in PubMed

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases Circulation. 2007 Mar 27; 115(12):1656-95. . View in PubMed

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases J Am Coll Cardiol. 2007 Mar 27; 49(12):1373-412. . View in PubMed

ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threatsTask Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. J Am Coll Cardiol. 2007 Mar 27; 49(12):1389-97. . View in PubMed

Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing Am J Cardiol. 2006 Jun 15; 97(12):1778-84. . View in PubMed

Attempts to recruit stem cells for repair of acute myocardial infarction: a dose of reality JAMA. 2006 Mar 01; 295(9):1058-60. . View in PubMed

Cardiovascular effects of phosphodiesterase 5 inhibitors Curr Pharm Des. 2006; 12(27):3485-94. . View in PubMed

Cardiac cells implanted within the outer aortic wall of rats generate measurable contractile force Regen Med. 2006 Jan; 1(1):119-24. . View in PubMed

Commentaries on Jackson et al"Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction". J Sex Med. 2005 Sep; 2(5):740-2; author reply 742. . View in PubMed

Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat J Cardiovasc Pharmacol. 2005 Aug; 46(2):211-5. . View in PubMed

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects Circulation. 2005 Jul 12; 112(2):214-23. . View in PubMed

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol. 2005 Jun 07; 45(11):1775-80. . View in PubMed

Acetaminophen and myocardial stunning after transient ischemia in rabbit hearts J Cardiovasc Pharmacol Ther. 2005 Jun; 10(2):121-9. . View in PubMed

Coronary No-reflow Phenomenon Curr Treat Options Cardiovasc Med. 2005 May; 7(1):75-80. . View in PubMed

Benefit of an exercise program before myocardial infarction J Am Coll Cardiol. 2005 Mar 15; 45(6):939-40. . View in PubMed

Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction Circulation. 2004 Nov 09; 110(19):3149-55. . View in PubMed

Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol. 2004 Jul 21; 44(2):276-86.. View in PubMed

Effects of adenosine and verapamil on anatomic no-reflow in a rabbit model of coronary artery occlusion and reperfusion J Cardiovasc Pharmacol. 2004 Apr; 43(4):580-8. . View in PubMed

Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient Endocrine. 2004 Mar-Apr; 23(2-3):125-9. . View in PubMed

Acetaminophen and experimental acute myocardial infarction Cardiovasc Drugs Ther. 2004 Mar; 18(2):121-5. . View in PubMed

Age-related changes of cardiac gene expression following myocardial ischemia/reperfusion Arch Biochem Biophys. 2003 Dec 15; 420(2):268-78. . View in PubMed

Effects of acetaminophen on myocardial infarct size in rats J Cardiovasc Pharmacol Ther. 2003 Dec; 8(4):277-84. . View in PubMed

Cardiovascular effects of tadalafil Am J Cardiol. 2003 Nov 06; 92(9A):37M-46M. . View in PubMed

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies Am J Cardiol. 2003 Nov 06; 92(9A):47M-57M. . View in PubMed

Cardiovascular mortality in New York City after September 11, 2001 Am J Cardiol. 2003 Oct 01; 92(7):857-61. . View in PubMed

Coronary no-flow and ventricular tachycardia associated with habitual marijuana use Ann Emerg Med. 2003 Sep; 42(3):365-9. . View in PubMed

Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation Cardiovasc Res. 2003 Aug 01; 59(2):441-9. . View in PubMed

Brief episode of ischemia activates protective genetic program in rat heart: a gene chip study Cardiovasc Res. 2003 Aug 01; 59(2):450-9. . View in PubMed

Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure? Heart Fail Rev. 2003 Jul; 8(3):201-11.. View in PubMed

Development of abnormal tissue architecture in transplanted neonatal rat myocytes Ann Thorac Surg. 2003 May; 75(5):1450-6. . View in PubMed

Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res. 2003 May 01; 58(2):358-68.. View in PubMed

Cocaine and the heart N Engl J Med. 2003 Feb 06; 348(6):487-8. . View in PubMed

Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair Circulation. 2002 Sep 24; 106(12 Suppl 1):I125-30. . View in PubMed

A 4-year update on the safety of sildenafil citrate (Viagra) Urology. 2002 Sep; 60(2 Suppl 2):67-90. . View in PubMed

Cellular cardiomyoplasty--a novel approach to treat heart disease Congest Heart Fail. 2002 Jul-Aug; 8(4):220-7. . View in PubMed

Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period Am J Cardiol. 2002 Jun 01; 89(11):1291-3. . View in PubMed

Powered by SC CTSI
Go to Top